References
- Ereshefsky L, Watanabe MD, Tran-Johnson TK: Clo-zapine: An atypical antipsychotic agent. Clin Pharm 8:691–709, 1989
- Naber D, Hippius H: The European experience with the use of clozapine. Hosp Community Psychiatry 41:886–890, 1990
- Kane J, Honigfeld G, Singer J, et at.: Clozapine for the treatment resistant schizophrenic. Arch Gen Psychia-try 45:783–796, 1988
- Meltzer HY, Burnett S, Bastani B, et al.: Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients. Hosp Community Psychiatry 41:892–897, 1990
- Conley RR, Baker RW: Family response to improve-ment by a relative with schizophrenia. Hosp Com-munity Psychiatry 8:898–901, 1990
- Wilson WH. Initial experience with clozapine in a state hospital. Hosp Community Psychiatry 43:700–703, 1992
- Wilson WH: Outcome of clozapine treatment at one year in a state hospital: A clinical review. Society of Biological Psychiatry, 1992 Convention and Scientific Program, Washington, D.C., April 29—May 3, 1992
- Wilson WH: Clinical review of clozapine treatment in a state hospital. 145th Annual Meeting, American Psy-chiatric Association, Washington, D.C., May 2–7, 1992
- Heindrichs DW, Hanlon ET, Carpenter WT Jr.: The Quality of Life Scale: An instrument for rating the schizophrenic deficit syndrome. Schizophr Bull 10:388–398, 1984
- Overall JE, Gorham DR: The Brief Psychiatric Rating Scale. Psychol Rep 10:799–812, 1962